GYN pt 2 Preterm Labor, Alloimmunization, IUGR, and IUFD
Preterm Labor and Clinical Assessment
Preterm Dimensions and Loss Definitions
Successive turns in labor categories often involve a history of loss.
A loss occurring before weeks is classified differently than a preterm birth.
In clinical history-taking, specific details matter: for example, a patient with two preterm births and one loss who has two surviving children.
Clinical Presentation and Diagnosis
There is a clinical adage: "When it looks like a duct and it looks like a duct and it looks like a duct, usually, it's a duct." This emphasizes that if a patient's symptoms match their past history of preterm labor, it is likely occurring again.
Risk factors include a history of previous preterm labor. For a -year-old patient contracting painfully every few minutes for two hours with a history of two previous preterm incidents, there is a very high probability of recurrence.
Statistics indicate that about one-third of patients experiencing these symptoms will have the labor stop on its own without any medical intervention.
Objective Measures for Diagnosis:
Ultrasound for Cervical Length: A normal cervix should ideally be more than () in length. Clinical concern increases significantly if the length is less than .
Fetal Fibronectin: This test, along with cervical length, has a poor positive predictive value but a very good secondary negative predictive value.
Treatment of Preterm Labor (Tocolytics)
Tocolytic medications are used to delay labor, typically providing a window of approximately hours.
Contraindications for Tocolysis:
Non-viable fetus.
Fetal demise (intrauterine fetal death).
Non-reassuring fetal heart rate (indicating an urgent need for delivery).
Severe preeclampsia/eclampsia (severe tinctures).
Severe fetal anomalies.
Patient intolerance to the medication.
Preterm premature rupture of membranes (PPROM).
Patient instability.
Medical contraindications to specific drugs.
Pharmacological Options:
Calcium Channel Blockers: Most commonly Nifedipine.
NSAIDs: Most commonly Indomethacin.
Beta-adrenergic receptor agonists: Such as Terbutaline.
Magnesium Sulfate (): Used specifically for fetal neuroprotection to prevent cerebral palsy if the patient is less than weeks gestation.
Steroid Administration for Fetal Lung Maturity
Betamethasone: Administered once a day.
Dexamethasone: Administered twice a day.
Neuroprotection: Magnesium sulfate is utilized for neuroprotection up to weeks; beyond this threshold, the benefit for preventing cerebral palsy is not established.
Alloimmunization and Rh Incompatibility
Pathophysiology of Alloimmunization
This condition occurs in Rh-negative mothers pregnant with an Rh-positive fetus.
It affects approximately of all pregnancies.
The most common event leading to alloimmunization is childbirth, as this is when the largest mixture of fetal and maternal blood occurs. However, in the first trimester, even as little as (a tenth of a CC) of blood can trigger the immune response.
Mechanism: Exposure to fetal Red Blood Cells (RBCs) activates the maternal immune system to form IgG antibodies. These antibodies cross the placenta and rupture fetal RBCs, leading to fetal anemia.
Fetal Consequences
Bilirubin Leakage: Ruptured cells release bilirubin. In severe cases, an accumulation of bilirubin leads to Kernicterus, which can result in developmental delays and intellectual disabilities.
Hydrops Fetalis: Damage to the fetal liver leads to decreased oncotic pressure. This results in:
Splenomegaly (due to the destruction of RBCs).
Pleural and pericardial effusions.
Ascites (accumulation of fluid in the abdomen).
High-output cardiac failure.
Clinical Management
Screening: Check for Anti-D antibodies and determine titers. Titers should be repeated every weeks to monitor severity.
RhoGAM: Administered to Rh-negative mothers to prevent sensitization.
Assessing the Fetus:
Fetal DNA: Can be obtained via amniocentesis if the father's Rh status is unknown or if there is uncertainty regarding paternity.
Middle Cerebral Artery (MCA) Doppler: An ultrasound method to qualitatively assess if the fetus is anemic.
Percutaneous Umbilical Blood Sampling (PUBS): An invasive test to measure fetal hematocrit directly.
Normal fetal hematocrit: .
Severe anemia: Less than .
Transfusion: Blood can be transfused to the fetus in utero via the umbilical cord.
Delivery Timing: For mild hemolysis, labor can be induced. If the fetus has required transfusion, delivery is typically planned by to weeks.
Intrauterine Growth Restriction (IUGR)
Definition and Metrics
IUGR is defined as a fetus at or below the percentile for weight for their specific gestational age.
Ultrasound Parameters used to estimate fetal weight (EFW):
Head Circumference (HC).
Biparietal Diameter (BPD).
Abdominal Circumference (AC).
Femur Length (FL).
Terminology Note: "Small for Gestational Age" (SGA) should only be used for infants after birth, not for fetuses in utero.
Etiology of IUGR
Hypertensive disorders.
Renal insufficiency.
Substance use (specifically Cocaine or Amphetamines).
Antiphospholipid antibody syndrome.
Malarial infections.
TORCH Infections: Toxoplasmosis, Other (Syphilis, Varicella, Mumps, HIV), Rubella, Cytomegalovirus (CMV), and Herpes Simplex.
Classification of IUGR
Symmetric IUGR: The entire fetus is small, including the head.
Asymmetric IUGR: The head size is normal, but the body (specifically the abdomen) is disproportionately small.
Management and Delivery
The uterus may become an environment that is worse for the fetus than the outside world.
Delivery is generally recommended at weeks if the baby is at or less than the percentile. If the percentile is slightly better, delivery may occur at weeks.
Intrauterine Fetal Demise (IUFD)
Definitions and Forensic Distinctions
IUFD is the death of a fetus in utero. It occurs in less than of deliveries.
Legal/Forensic distinction: In cases of potential criminal penalties, it must be determined if the fetus ever breathed. If there is no effort at breathing, no palpable heart rate, no cord pulsations, and no brain movement, it is classified as a fetal death rather than a live birth.
Risk Factors and Gestational Age Peaks
The risk of loss is lowest around weeks.
The risk increases significantly at weeks.
At weeks, the risk increase is described as being as steep as the "altitude of Mount Everest."
Maternal Age: At age or older, the likelihood of losing a pregnancy in the first trimester is approximately .
Clinical Presentation and Diagnosis
Classic presentation: "I haven't felt the baby move."
Diagnosis: Absence of fetal cardiac activity must be certified via ultrasound. Institutions often require a senior professional (Chief Resident, Attending, or Maternal Fetal Medicine specialist) to confirm the diagnosis to avoid errors.
Medical Management and Complications
Coagulopathy: A decomposing fetus can cause an increase in tissue thromboplastin, putting the mother at risk for disseminated intravascular coagulation (DIC).
Mode of Delivery: Vaginal delivery is overwhelmingly preferred as it is safer and avoids the risks of major surgery. It also allows for higher levels of sedation since fetal well-being is no longer a factor.
Surgical alternatives: In cases where labor is contraindicated (e.g., multiple previous classical C-sections), a surgical evacuation or dismantling through the cervix may be necessary under anesthesia.
Psychosocial and Bereavement Care
Communication: Providers should sit down when delivering bad news to avoid appearing rushed or intimidating.
Bereavement Teams: Composed of nursing staff, social workers, and pastoral care. They help with memory packs (e.g., photos, handprints) and suppressing lactation (e.g., packs to the breast).
Autopsy: Patients have the right to request an autopsy, sometimes requesting an outside pathologist if there is a lack of trust in the institution.
Recurrence Risk: The risk of a subsequent IUFD in a future pregnancy is higher. Management for future pregnancies involves individualized care and delivery between and weeks.
Questions & Discussion
Question: Would these [IUFD cases] be Category III on a tracing?
Response: Not necessarily, though they might be. The issue is that while we monitor patients intensely in labor and delivery, there is often no monitoring happening during the patient's daily life (e.g., while they are shopping), making the exact onset of demise difficult to determine.
Discussion on Paternity: When assessing Rh status, providers should maintain a degree of skepticism regarding the stated father's identity. If the father is not available or the relationship is severed, fetal DNA from amniocentesis is the only definitive way to know the fetal Rh status.
Discussion on Pathology Results: Toxicology studies for IUFD typically take about weeks, which is often what patients are waiting for when results are "pending."